Innovation and quality in a global context.
The medical cannabis industry is constantly evolving. In this global scenario, Linneo Health is leading the way in developing breakthrough innovations in the sector thanks to the permanent improvement of our manufacturing processes and always striving for excellence which allows us to offer the best in class products.
Quality: Our value proposition
Quality is the cornerstone of our activity. We cultivate the highest quality cannabis, in compliance with the requirements of the current regulations and the strictest customers. We follow industry best practices at every stage of our manufacturing process, applying the most advanced cultivation techniques and the industrial experience of more than 50 years in the manufacture and purification of extracts.
All together has allowed us to become pioneers in receiving the GMP (Good Manufacturing Practices) quality certificate from the Spanish Agency for Medicines and Health Products (AEMPS). This extraordinary milestone is the result of our commitment to bring only the best products to the end market. You can view our certificate here.
R&D at the heart of our business
Our team is continuously developing more efficient and innovative manufacturing processes, always aiming for excellence and in accordance with the most rigorous quality standards.
Our investment in agricultural R&D programs, together with our ability to control all the extraction methods, makes us one of the most innovative companies within the market.
The commitment, collective effort and high technological component of our R&D activities have allowed us to be awarded with public institutions.
CANNABI+D Project. IDI-20190621
The objective of the project focuses on the development of the production process of cannabis sativa focused on the stages of maturation and drying of the product This project has been co-financed by the European Regional Development Fund (ERDF), within the Pluriregional Operational Program of Spain 2014-2020.
CDTI Contribution: 205,707.16 €.